ATTACHMENT_NO._01-PURCHASE_DESCRIPTION_PROMEGA_P450-GLO.PDF
Published: 08/20/2018
Description
Version 11-30-2016-1 FAR Part 11—Describing Agency Needs PURCHASE DESCRIPTION 1. Statement of Need and Purpose: The Tox21 group (NCATS) requires P450-Glo assay systems (CYP3A4 with Luciferin-PPXE, CYP2D6, and CYP1A2). These assay kits will be us...
